Status:

COMPLETED

Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)

Lead Sponsor:

Beth Israel Deaconess Medical Center

Collaborating Sponsors:

BIRD (Israel-United States Binational Industrial Research and Development) Foundation- Funding agency

Rabin Medical Center

Conditions:

Delirium

Delirium in Old Age

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The purpose of this research is to investigate whether addition of the EyeControl-Pro platform as an adjunct to standard guideline-based intensive care unit management of critically ill patients is ef...

Detailed Description

This is a prospective, binational, single-blind, multicenter, randomized control trial, conducted according to international good clinical practice (GCP) ethical and quality standards. Critically ill,...

Eligibility Criteria

Inclusion

  • Mechanically ventilated patients aged \>=50 years
  • RASS score of -3 to +1 and
  • Anticipated to require \>=24 hours of mechanical ventilation

Exclusion

  • Not expected to survive \>=24 hours
  • Have limitations in care (Do Not Resuscitate, or comfort-focused care orders)
  • Receiving paralytic neuromuscular blocking agent (NMBA) infusion or anticipated need for NMBA use
  • Have advanced dementia or cognitive impairment including post-concussive syndrome.
  • Have severe uncorrected psychiatric disorders.
  • Have uncorrected hearing or visual impairment.
  • Acute or subacute neurological disorder hindering communication or ability to participate in CAM ICU assessments
  • Enrolled in a clinical trial which prohibits co-enrollment.
  • Incarcerated
  • Have no identified legally appointed representative (LAR)
  • Are unable to communicate in the predominant local language (English at US site and English/Hebrew/Arabic/Russian in Israel)
  • Refusal of treating clinical team.

Key Trial Info

Start Date :

February 25 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 18 2025

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06029244

Start Date

February 25 2024

End Date

November 18 2025

Last Update

December 3 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

2

Assuta Ashdod Medical Center

Ashdod, Israel

3

Rabin Medical Center

Petah Tikva, Israel